Product Information

AMLODIPINE-OLMESARTAN 10-20 MG is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2719 per EA under NDC 33342019207. Its NADAC has been published 508 times since Feb 22, 2017.

FDA first approved this application on Oct 26, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-OLMESARTAN 10-20 MG

AMLODIPINE and OLMESARTAN medoxomil
$0.2719per EA

Strength

10; 20 mg/1; mg/1

NDC

33342019207

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206884

FDA Approved

10/26/2016

TE Code

AB

On Market Since

10/27/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has been published 508 times since Feb 22, 2017, and over the history we have for it it has declined 71.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2719 per EA
All-time high$0.9788 (Oct 11, 2017)
All-time low$0.2298 (Aug 19, 2026)
52-week high$0.3303
52-week low$0.2298
Median price$0.4377
Average price$0.5286
Largest weekly change+68.6% (Nov 22, 2023)
Weeks tracked508
Tracking sinceFeb 22, 2017

Price History

1W

0.0%

1M

+9.8%

3M

+18.3%

6M

-7.9%

1Y

-15.5%

3Y

-9.2%

5Y

-2.8%

All

-71.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMLODIPINE-OLMESARTAN 10-20 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-20 MG, manufactured by Macleods Pharmaceuticals Limited, is $0.2719 per EA (NDC 33342019207), effective Nov 11, 2026.

How has the price of AMLODIPINE-OLMESARTAN 10-20 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has declined 71.9%. It has been tracked across 508 weekly CMS publications since Feb 22, 2017.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-20 MG?

Since Feb 22, 2017, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has ranged from a low of $0.2298 (Aug 19, 2026) to a high of $0.9788 (Oct 11, 2017), with a median of $0.4377 per EA.

Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-20 MG?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-OLMESARTAN 10-20 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-OLMESARTAN 10-20 MG?

AMLODIPINE-OLMESARTAN 10-20 MG (NDC 33342019207) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.